S. Ozcelik Et Al. , "BRAF V600E mutation in papillary thyroid cancer is correlated with adverse clinicopathological features but not with iodine exposure," ENDOKRYNOLOGIA POLSKA , vol.70, pp.401-408, 2019
Ozcelik, S. Et Al. 2019. BRAF V600E mutation in papillary thyroid cancer is correlated with adverse clinicopathological features but not with iodine exposure. ENDOKRYNOLOGIA POLSKA , vol.70 , 401-408.
Ozcelik, S., Bircan, R., Sarikaya, S., Gul, A. E., Aydin, B., Ozcelik, M., ... Celik, M.(2019). BRAF V600E mutation in papillary thyroid cancer is correlated with adverse clinicopathological features but not with iodine exposure. ENDOKRYNOLOGIA POLSKA , vol.70, 401-408.
Ozcelik, Serhat Et Al. "BRAF V600E mutation in papillary thyroid cancer is correlated with adverse clinicopathological features but not with iodine exposure," ENDOKRYNOLOGIA POLSKA , vol.70, 401-408, 2019
Ozcelik, Serhat Et Al. "BRAF V600E mutation in papillary thyroid cancer is correlated with adverse clinicopathological features but not with iodine exposure." ENDOKRYNOLOGIA POLSKA , vol.70, pp.401-408, 2019
Ozcelik, S. Et Al. (2019) . "BRAF V600E mutation in papillary thyroid cancer is correlated with adverse clinicopathological features but not with iodine exposure." ENDOKRYNOLOGIA POLSKA , vol.70, pp.401-408.
@article{article, author={Serhat Ozcelik Et Al. }, title={BRAF V600E mutation in papillary thyroid cancer is correlated with adverse clinicopathological features but not with iodine exposure}, journal={ENDOKRYNOLOGIA POLSKA}, year=2019, pages={401-408} }